Bristol Myers Squibb to Participate in Citi’s 2025 Global Healthcare Conference

Audio By Carbonatix

PRINCETON, N.J.--(BUSINESS WIRE)--Nov 26, 2025--

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in Citi’s 2025 Global Healthcare Conference on Thursday, December 4, 2025.

The company will take part in a fireside chat beginning at 9:00 a.m. ET.

Investors and the general public are invited to listen to the session by visiting http://investor.bms.com. An archived edition of the session will be available following its conclusion.

About Bristol Myers Squibb: Transforming Patients’ Lives Through Science
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com and follow us on LinkedIn, X, YouTube, Facebook and Instagram.

corporatefinancial-news

View source version on businesswire.com:https://www.businesswire.com/news/home/20251126070653/en/

CONTACT: Media Relations:

[email protected]

Investor Relations:

[email protected]

KEYWORD: NEW JERSEY UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH

SOURCE: Bristol Myers Squibb

Copyright Business Wire 2025.

PUB: 11/26/2025 06:59 AM/DISC: 11/26/2025 07:00 AM

http://www.businesswire.com/news/home/20251126070653/en